查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
神經補綴的全球市場(2022年～2028年)
市場調查報告書
商品編碼
1159376

神經補綴的全球市場(2022年～2028年)

Neuroprosthetics Market 2022-2028
出版日期: | 出版商: Orion Market Research | 英文 125 Pages | 商品交期: 2-3個工作天內

價格

全球神經補綴的市場規模，在預測期間內預計以12.7％的年複合成長率成長。牽引這個市場的主要原因，有高齡化人口增加等。

本報告提供全球神經補綴市場調查，市場概要，市場的推動因素與阻礙因素的分析，市場機會，各市場區隔，各地區的市場分析，主要企業的簡介等，系統性資訊。

目錄

第1章 報告概要

第2章 市場概要與洞察

  • 調查範圍
  • 分析師的洞察和目前市場趨勢

第3章 競爭情形

  • Medtronic
    • 概要
    • 財務分析
    • SWOT分析
    • 最近的趨勢
  • Cochlear Ltd.
    • 概要
    • 財務分析
    • SWOT分析
    • 最近的趨勢
  • LivaNova PLC
    • 概要
    • 財務分析
    • SWOT分析
    • 最近的趨勢
  • Demant A/S.
    • 概要
    • 財務分析
    • SWOT分析
    • 最近的趨勢
  • MED-EL Medical Electronics
    • 概要
    • 財務分析
    • SWOT分析
    • 最近的趨勢
  • 主要策略分析
  • COVID-19對主要企業的影響

第4章 市場區隔

  • 各類型
    • 馬達補綴
    • 感覺補綴
    • 認識補綴
    • 視覺補綴
  • 各治療技術
    • 腦深部刺激(DBS)
    • 迷走神經刺激(VNS)
    • 薦骨神經刺激器(SNS)
    • 脊髓刺激設備(SCS)
  • 各用途
    • 異動症
    • 生理障礙
    • 認知障礙

第5章 地區分析

  • 北美
    • 美國
    • 加拿大
  • 歐洲
    • 英國
    • 德國
    • 義大利
    • 西班牙
    • 法國
    • 其他的歐洲
  • 亞太地區
    • 中國
    • 印度
    • 日本
    • 韓國
    • 其他的亞太地區
  • 全球其他地區

第6章 企業簡介

  • Abbott Laboratories
  • ALEVA NEUROTHERAPEUTICS SA
  • Bioventus Inc.
  • Boston Scientific Corp.
  • CorTec GmbH
  • electroCore, Inc.
  • Functional Neuromodulation Ltd.
  • Mass General Brigham Inc
  • Neuronetics, Inc.
  • NeuroPace, Inc.
  • Nevro Corp.
  • Oticon Medical A/S
  • ReShape Lifesciences Inc.
  • Sonova AG
  • Soterix Medical Inc.
Product Code: OMR2026510

Title: Global Neuroprosthetics Market Size, Share & Trends Analysis Report by Type (Motor Prosthetics, Sensory Prosthetics, Cognitive Prosthetics, and Visual Prosthetics), by Treatment Technique (Deep Brain Stimulation (DBS), Vagus Nerve Stimulation (VNS), Sacral Nerve Stimulator (SNS), and Spinal Cord Stimulator (SCS) and by Application (Motor Disorder, Physiological Disorder, and Cognitive Disorder) Forecast Period (2022-2028).

The global neuroprosthetics market is anticipated to grow at a substantial CAGR of 12.7% during the forecast period. The factor that grows the global neuroprosthetics market is due to the increasing aging population and requires considerable attention to address the treatment issues as all the cases do not respond to medication therapy. According to Eurostat, 20.6% population is aged 65 and over. The share of people aged 80 years and above in the EU population will be increased by 5.9% to 14.6% between 2020 to 2100.

The global neuroprosthetics market is segmented based on the type, treatment technique, and application. Based on the type, the market is segmented into motor prosthetics, sensory prosthetics, cognitive prosthetics, and visual prosthetics. Based on the treatment technique, the market is sub-segmented into the deep brain stimulation (DBS), vagus nerve stimulation (VNS), sacral nerve stimulator (SNS), and spinal cord stimulator (SCS). Based on the application, the market is sub-segmented into the motor disorder, physiological disorder, and cognitive disorder. The above mentioned segments can be customized as per the requirements. The cognitive prosthetics segment is expected to cater to a significant share in the global neuroprosthetics market due to the increasing number of people suffering from hearing issues. According to the Hearing Loss Association of America, 2020, nearly 48 million Americans had some degree of hearing loss, and an estimated 50 million Americans experience tinnitus, which is ringing in the ears, among which 90% have hearing loss.

Geographically market is segmented into North America, Europe, Asia Pacific, and the Rest of the World. Europe is expected to cater a significant share in the global neuroprosthetics market due to increase in the number of diseases. According to WHO survey, brain disorders are responsible for 35% of Europe's total disease burden.

The major companies serving the global neuroprosthetics market include Abbott Laboratories, Boston Scientific Corporation, BrainGate, Cochlear Ltd, Cyberonics Inc., Medtronic Inc., Livanova Plc, and others. The market players are considerably contributing to the market growth by the adoption of various strategies including mergers & acquisitions, collaborations, funding, and new product launches, to stay competitive in the market. For instance, in January 2021 Boston Scientific launched a limited market release of the WaveWriter Alpha portfolio of Spinal Cord Stimulator (SCS) systems. The unified portfolio of four MRI conditional, Bluetooth-enabled rechargeable and non-rechargeable implantable pulse generators (IPGs) provides uncompromised personalization, and for the first time in SCS, Fast Acting Sub-perception Therapy (FAST) designed to deliver profound paresthesia-free pain relief in minutes. The systems are supported by the Cognita Solutions suite of digital tools for patients and physicians.

Research Methodology

The market study of the global neuroprosthetics market is incorporated by extensive primary and secondary research conducted by the research team at OMR. Secondary research has been conducted to refine the available data to breakdown the market into various segments, derive total market size, market forecast, and growth rate. Different approaches have been worked on to derive the market value and market growth rate. Our team collects facts and data related to the market from different geography to provide a better regional outlook. In the report, the country-level analysis is provided by analyzing various regional players, regional tax laws and policies, consumer behavior, and macro-economic factors. Numbers extracted from secondary research have been authenticated by conducting proper primary research. It includes tracking down key people from the industry and interviewing them to validate the data. This enables our analyst to derive the closest possible figures without any major deviations in the actual number. Our analysts try to contact as many executives, managers, key opinion leaders, and industry experts. Primary research brings authenticity to our reports.

Secondary Sources Include:

  • Financial reports of companies involved in the market.
  • Whitepapers, research papers, and news blogs.
  • Company websites and their product catalog.

The report provides an in-depth analysis of market size, intended quality of the service preferred by consumers. The report will serve as a source for a 360-degree analysis of the market thoroughly integrating different models.

Market Segmentation

1. Global Neuroprosthetics Market Research and Analysis by Type

2. Global Neuroprosthetics Market Research and Analysis by Treatment Technique

3. Global Neuroprosthetics Market Research and Analysis by Application

The Report Covers:

  • Comprehensive Research Methodology of the global neuroprosthetics market.
  • This report also includes a detailed and extensive market overview with key analyst insights.
  • An exhaustive analysis of macro and micro factors influencing the market guided by key recommendations.
  • Analysis of regional regulations and other government policies impacting the global neuroprosthetics market.
  • Insights about market determinants that are stimulating the global neuroprosthetics market.
  • Detailed and extensive market segments with the regional distribution of forecasted revenues.
  • Extensive profiles and recent developments of market players.

Table of Contents

1. Report Summary

  • Current Industry Analysis and Growth Potential Outlook
  • Impact of COVID-19 on the Global Neuroprosthetics Market
  • Recovery Scenario of Global Neuroprosthetics Market
  • 1.1. Research Methods and Tools
  • 1.2. Market Breakdown
    • 1.2.1. By Segments
    • 1.2.2. BY Region

2. Market Overview and Insights

  • 2.1. Scope of the Report
  • 2.2. Analyst Insight & Current Market Trends
    • 2.2.1. Key Findings
    • 2.2.2. Recommendations
    • 2.2.3. Conclusion

3. Competitive Landscape

  • 3.1. Medtronic
    • 3.1.1. Overview
    • 3.1.2. Financial Analysis
    • 3.1.3. SWOT Analysis
    • 3.1.4. Recent Developments
  • 3.2. Cochlear Ltd.
    • 3.2.1. Overview
    • 3.2.2. Financial Analysis
    • 3.2.3. SWOT Analysis
    • 3.2.4. Recent Developments
  • 3.3. LivaNova PLC
    • 3.3.1. Overview
    • 3.3.2. Financial Analysis
    • 3.3.3. SWOT Analysis
    • 3.3.4. Recent Developments
  • 3.4. Demant A/S.
    • 3.4.1. Overview
    • 3.4.2. Financial Analysis
    • 3.4.3. SWOT Analysis
    • 3.4.4. Recent Developments
  • 3.5. MED-EL Medical Electronics
    • 3.5.1. Overview
    • 3.5.2. Financial Analysis
    • 3.5.3. SWOT Analysis
    • 3.5.4. Recent Developments
  • 3.6. Key Strategy Analysis
  • 3.7. Impact of Covid-19 on Key Players

4. Market Segmentation

  • 4.1. Global Neuroprosthetics Market by Type
    • 4.1.1. Motor Prosthetics
    • 4.1.2. Sensory Prosthetics
    • 4.1.3. Cognitive Prosthetics
    • 4.1.4. Visual Prosthetics
  • 4.2. Global Neuroprosthetics Market by Treatment Technique
    • 4.2.1. Deep Brain Stimulation (DBS)
    • 4.2.2. Vagus Nerve Stimulation(VNS)
    • 4.2.3. Sacral Nerve Stimulator(SNS)
    • 4.2.4. Spinal Cord Stimulator(SCS)
  • 4.3. Global Neuroprosthetics Market by Application
    • 4.3.1. Motor Disorder
    • 4.3.2. Physiological Disorder
    • 4.3.3. Cognitive Disorder

5. Regional Analysis

  • 5.1. North America
    • 5.1.1. United States
    • 5.1.2. Canada
  • 5.2. Europe
    • 5.2.1. UK
    • 5.2.2. Germany
    • 5.2.3. Italy
    • 5.2.4. Spain
    • 5.2.5. France
    • 5.2.6. Rest of Europe
  • 5.3. Asia-Pacific
    • 5.3.1. China
    • 5.3.2. India
    • 5.3.3. Japan
    • 5.3.4. South Korea
    • 5.3.5. Rest of Asia-Pacific
  • 5.4. Rest of the World

6. Company Profiles

  • 6.1. Abbott Laboratories
  • 6.2. ALEVA NEUROTHERAPEUTICS SA
  • 6.3. Bioventus Inc.
  • 6.4. Boston Scientific Corp.
  • 6.5. CorTec GmbH
  • 6.6. electroCore, Inc.
  • 6.7. Functional Neuromodulation Ltd.
  • 6.8. Mass General Brigham Inc
  • 6.9. Neuronetics, Inc.
  • 6.10. NeuroPace, Inc.
  • 6.11. Nevro Corp.
  • 6.12. Oticon Medical A/S
  • 6.13. ReShape Lifesciences Inc.
  • 6.14. Sonova AG
  • 6.15. Soterix Medical Inc.

LIST OF TABLES

  • 1. GLOBAL NEUROPROSTHETICS MARKET RESEARCH AND ANALYSIS BY TYPE, 2021-2028 ($ MILLION)
  • 2. GLOBAL MOTOR PROSTHETICS MARKET RESEARCH AND ANALYSIS BY REGION, 2021-2028 ($ MILLION)
  • 3. GLOBAL SENSORY PROSTHETICS MARKET RESEARCH AND ANALYSIS BY REGION, 2021-2028 ($ MILLION)
  • 4. GLOBAL COGNITIVE PROSTHETICS MARKET RESEARCH AND ANALYSIS BY REGION, 2021-2028 ($ MILLION)
  • 5. GLOBAL COGNITIVE PROSTHETICS MARKET RESEARCH AND ANALYSIS BY REGION, 2021-2028 ($ MILLION)
  • 6. GLOBAL NEUROPROSTHETICS MARKET RESEARCH AND ANALYSIS BY TREATMENT TECHNIQUE, 2021-2028 ($ MILLION)
  • 7. GLOBAL DEEP BRAIN STIMULATION (DBS) FOR NEUROPROSTHETICS MARKET RESEARCH AND ANALYSIS BY REGION, 2021-2028 ($ MILLION)
  • 8. GLOBAL VAGUS NERVE STIMULATION (VNS) FOR NEUROPROSTHETICS MARKET RESEARCH AND ANALYSIS BY REGION, 2021-2028 ($ MILLION)
  • 9. GLOBAL SACRAL NERVE STIMULATOR (SNS) FOR NEUROPROSTHETICS MARKET RESEARCH AND ANALYSIS BY REGION, 2021-2028 ($ MILLION)
  • 10. GLOBAL SPINAL CORD STIMULATOR (SCS) FOR NEUROPROSTHETICS MARKET RESEARCH AND ANALYSIS BY REGION, 2021-2028 ($ MILLION)
  • 11. GLOBAL NEUROPROSTHETICS MARKET RESEARCH AND ANALYSIS BY APPLICATION, 2021-2028 ($ MILLION)
  • 12. GLOBAL NEUROPROSTHETICS FOR MOTOR DISORDER MARKET RESEARCH AND ANALYSIS BY REGION, 2021-2028 ($ MILLION)
  • 13. GLOBAL NEUROPROSTHETICS FOR PHYSIOLOGICAL DISORDER MARKET RESEARCH AND ANALYSIS BY REGION, 2021-2028 ($ MILLION)
  • 14. GLOBAL NEUROPROSTHETICS FOR COGNITIVE DISORDER MARKET RESEARCH AND ANALYSIS BY REGION, 2021-2028 ($ MILLION)
  • 15. GLOBAL NEUROPROSTHETICS MARKET RESEARCH AND ANALYSIS BY GEOGRAPHY, 2021-2028 ($ MILLION)
  • 16. NORTH AMERICAN NEUROPROSTHETICS MARKET RESEARCH AND ANALYSIS BY COUNTRY, 2021-2028 ($ MILLION)
  • 17. NORTH AMERICAN NEUROPROSTHETICS MARKET RESEARCH AND ANALYSIS BY TYPE, 2021-2028 ($ MILLION)
  • 18. NORTH AMERICAN NEUROPROSTHETICS MARKET RESEARCH AND ANALYSIS BY TREATMENT TECHNIQUE, 2021-2028 ($ MILLION)
  • 19. NORTH AMERICAN NEUROPROSTHETICS MARKET RESEARCH AND ANALYSIS BY APPLICATION, 2021-2028 ($ MILLION)
  • 20. EUROPEAN NEUROPROSTHETICS MARKET RESEARCH AND ANALYSIS BY COUNTRY, 2021-2028 ($ MILLION)
  • 21. EUROPEAN NEUROPROSTHETICS MARKET RESEARCH AND ANALYSIS BY TYPE, 2021-2028 ($ MILLION)
  • 22. EUROPEAN NEUROPROSTHETICS MARKET RESEARCH AND ANALYSIS BY TREATMENT TECHNIQUE, 2021-2028 ($ MILLION)
  • 23. EUROPEAN NEUROPROSTHETICS MARKET RESEARCH AND ANALYSIS BY APPLICATION, 2021-2028 ($ MILLION)
  • 24. ASIA-PACIFIC NEUROPROSTHETICS MARKET RESEARCH AND ANALYSIS BY COUNTRY, 2021-2028 ($ MILLION)
  • 25. ASIA-PACIFIC NEUROPROSTHETICS MARKET RESEARCH AND ANALYSIS BY TYPE, 2021-2028 ($ MILLION)
  • 26. ASIA-PACIFIC NEUROPROSTHETICS MARKET RESEARCH AND ANALYSIS BY TREATMENT TECHNIQUE, 2021-2028 ($ MILLION)
  • 27. ASIA-PACIFIC NEUROPROSTHETICS MARKET RESEARCH AND ANALYSIS BY APPLICATION, 2021-2028 ($ MILLION)
  • 28. REST OF THE WORLD NEUROPROSTHETICS MARKET RESEARCH AND ANALYSIS BY COUNTRY, 2021-2028 ($ MILLION)
  • 29. REST OF THE WORLD NEUROPROSTHETICS MARKET RESEARCH AND ANALYSIS BY TYPE, 2021-2028 ($ MILLION)
  • 30. REST OF THE WORLD NEUROPROSTHETICS MARKET RESEARCH AND ANALYSIS BY TREATMENT TECHNIQUE, 2021-2028 ($ MILLION)
  • 31. REST OF THE WORLD NEUROPROSTHETICS MARKET RESEARCH AND ANALYSIS BY APPLICATION, 2021-2028 ($ MILLION)

LIST OF FIGURES

  • 1. IMPACT OF COVID-19 ON GLOBAL NEUROPROSTHETICS MARKET, 2021-2028 ($ MILLION)
  • 2. IMPACT OF COVID-19 ON GLOBAL NEUROPROSTHETICS MARKET BY SEGMENT, 2021-2028 ($ MILLION)
  • 3. RECOVERY OF GLOBAL NEUROPROSTHETICS MARKET, 2021-2027 (%)
  • 4. GLOBAL NEUROPROSTHETICS MARKET SHARE BY TYPE, 2020 VS 2027 (%)
  • 5. GLOBAL MOTOR PROSTHETICS MARKET SHARE BY GEOGRAPHY, 2020 VS 2027 (%)
  • 6. GLOBAL SENSORY PROSTHETICS MARKET SHARE BY GEOGRAPHY, 2020 VS 2027 (%)
  • 7. GLOBAL COGNITIVE PROSTHETICS MARKET SHARE BY GEOGRAPHY, 2020 VS 2027 (%)
  • 8. GLOBAL VISUAL PROSTHETICS MARKET SHARE BY GEOGRAPHY, 2020 VS 2027 (%)
  • 9. GLOBAL NEUROPROSTHETICS MARKET SHARE BY TREATMENT TECHNIQUE, 2020 VS 2027 (%)
  • 10. GLOBAL DEEP BRAIN STIMULATION (DBS) FOR NEUROPROSTHETICS MARKET SHARE BY GEOGRAPHY, 2020 VS 2027 (%)
  • 11. GLOBAL VAGUS NERVE STIMULATION (VNS) FOR NEUROPROSTHETICS MARKET SHARE BY GEOGRAPHY, 2020 VS 2027 (%)
  • 12. GLOBAL SACRAL NERVE STIMULATOR (SNS) FOR NEUROPROSTHETICS MARKET SHARE BY GEOGRAPHY, 2020 VS 2027 (%)
  • 13. GLOBAL SPINAL CORD STIMULATOR (SCS) FOR NEUROPROSTHETICS MARKET SHARE BY GEOGRAPHY, 2020 VS 2027 (%)
  • 14. GLOBAL NEUROPROSTHETICS MARKET SHARE BY APPLICATION, 2020 VS 2027 (%)
  • 15. GLOBAL NEUROPROSTHETICS FOR MOTOR DISORDER MARKET SHARE BY GEOGRAPHY, 2020 VS 2027 (%)
  • 16. GLOBAL NEUROPROSTHETICS FOR PHYSIOLOGICAL DISORDER MARKET SHARE BY GEOGRAPHY, 2020 VS 2027 (%)
  • 17. GLOBAL NEUROPROSTHETICS FOR COGNITIVE DISORDER MARKET SHARE BY GEOGRAPHY, 2020 VS 2027 (%)
  • 18. GLOBAL NEUROPROSTHETICS MARKET SHARE BY GEOGRAPHY, 2020 VS 2027 (%)
  • 19. US NEUROPROSTHETICS MARKET SIZE, 2021-2028 ($ MILLION)
  • 20. CANADA NEUROPROSTHETICS MARKET SIZE, 2021-2028 ($ MILLION)
  • 21. UK NEUROPROSTHETICS MARKET SIZE, 2021-2028 ($ MILLION)
  • 22. FRANCE NEUROPROSTHETICS MARKET SIZE, 2021-2028 ($ MILLION)
  • 23. GERMANY NEUROPROSTHETICS MARKET SIZE, 2021-2028 ($ MILLION)
  • 24. ITALY NEUROPROSTHETICS MARKET SIZE, 2021-2028 ($ MILLION)
  • 25. SPAIN NEUROPROSTHETICS MARKET SIZE, 2021-2028 ($ MILLION)
  • 26. REST OF EUROPE NEUROPROSTHETICS MARKET SIZE, 2021-2028 ($ MILLION)
  • 27. INDIA NEUROPROSTHETICS MARKET SIZE, 2021-2028 ($ MILLION)
  • 28. CHINA NEUROPROSTHETICS MARKET SIZE, 2021-2028 ($ MILLION)
  • 29. JAPAN NEUROPROSTHETICS MARKET SIZE, 2021-2028 ($ MILLION)
  • 30. SOUTH KOREA NEUROPROSTHETICS MARKET SIZE, 2021-2028 ($ MILLION)
  • 31. REST OF ASIA-PACIFIC NEUROPROSTHETICS MARKET SIZE, 2021-2028 ($ MILLION)
  • 32. REST OF THE WORLD NEUROPROSTHETICS MARKET SIZE, 2021-2028 ($ MILLION)